(CLDX) Celldex Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Celldex Therapeutics | (CLDX) share price targets
Complete technical analysis of Celldex Therapeutics (CLDX) by charts plus indicators, forecast predictions and share price targets for Celldex Therapeutics (CLDX)
Celldex Therapeutics trades in USA in Health Care sector.
10 day averaged volume of Celldex Therapeutics is 1726960
| Date | Daily Closing Price | Open | High | Low | Volume |
| 22 Fri Aug 2025 | 22.46 | 22.11 | 22.75 | 21.56 | 1.041 times |
| 21 Thu Aug 2025 | 22.02 | 20.71 | 22.32 | 20.37 | 1.406 times |
| 20 Wed Aug 2025 | 20.89 | 21.96 | 23.08 | 20.84 | 1.791 times |
| 19 Tue Aug 2025 | 24.02 | 24.48 | 24.65 | 23.69 | 0.789 times |
| 18 Mon Aug 2025 | 24.48 | 25.15 | 25.54 | 24.14 | 0.967 times |
| 15 Fri Aug 2025 | 25.50 | 25.05 | 25.65 | 24.66 | 0.811 times |
| 14 Thu Aug 2025 | 24.94 | 24.50 | 25.19 | 24.29 | 0.637 times |
| 13 Wed Aug 2025 | 24.99 | 24.42 | 25.79 | 23.93 | 1.176 times |
| 12 Tue Aug 2025 | 23.80 | 20.24 | 23.88 | 20.19 | 1.091 times |
| 11 Mon Aug 2025 | 20.01 | 20.54 | 21.55 | 19.72 | 0.885 times |
My analysis of stock is bearish for shortterm, and stock might move down till 21.1 or till 19.3. Use a stoploss of 22.64 and if the stock hits stoploss, then it can shoot up till 24.15
Share price targets for Celldex Therapeutics (CLDX)
| Target Type | Value |
| Downside Target | 14.40 |
| Downside Target | 17.85 |
| Downside Target | 19.25 |
| Downside Target | 19.72 |
| Downside Target | 21.23 |
| Upside Target | 22.60 |
| Upside Target | 23.47 |
| Upside Target | 24.03 |
| Upside Target | 24.06 |
| Upside Target | 25.54 |
| Upside Target | 25.79 |
Intraday share price targets for Celldex Therapeutics (CLDX)
| Target Type | Value |
| Downside Intraday Target | 20.04 |
| Downside Intraday Target | 17.62 |
| Upside Intraday Target | 25.21 |
| Upside Intraday Target | 27.96 |
| Upside Intraday Target | 22.79 |
Weekly technical analysis of Celldex Therapeutics (CLDX)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 22 Fri Aug 2025 | 22.46 | 25.15 | 25.54 | 20.37 | 1.303 times |
| 15 Fri Aug 2025 | 25.50 | 20.54 | 25.79 | 19.72 | 2.245 times |
| 08 Fri Aug 2025 | 20.66 | 21.65 | 22.60 | 20.10 | 0.804 times |
| 01 Fri Aug 2025 | 22.19 | 23.30 | 23.47 | 21.57 | 0.974 times |
| 25 Fri Jul 2025 | 23.35 | 22.42 | 24.06 | 21.71 | 1.119 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Celldex Therapeutics (CLDX)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 22 Fri Aug 2025 | 22.46 | 21.81 | 25.79 | 19.72 | 1.092 times |
| 31 Thu Jul 2025 | 21.98 | 20.31 | 24.06 | 20.01 | 0.909 times |
| 30 Mon Jun 2025 | 20.35 | 19.79 | 24.03 | 19.25 | 1.183 times |
| 30 Fri May 2025 | 19.78 | 20.61 | 21.23 | 17.85 | 1.135 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Celldex Therapeutics (CLDX)
Price action analysis of Celldex Therapeutics ( (CLDX) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Celldex Therapeutics ( (CLDX) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Celldex Therapeutics ( (CLDX) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Celldex Therapeutics ( (CLDX) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Celldex Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Celldex Therapeutics in short term but the sell signal is initial and weak.
Celldex Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a buy signal for Celldex Therapeutics in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Celldex Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 23.03 and Celldex Therapeutics (CLDX) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Celldex Therapeutics (CLDX) stock. Volume based technical analysis of Celldex Therapeutics (CLDX) stock is negative.
Celldex Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Celldex Therapeutics ( (CLDX) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Celldex Therapeutics ( (CLDX) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Celldex Therapeutics ( (CLDX) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Celldex Therapeutics ( (CLDX) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Celldex Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Celldex Therapeutics in short term but the sell signal is initial and weak.
Celldex Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a buy signal for Celldex Therapeutics in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Celldex Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 23.03 and Celldex Therapeutics (CLDX) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Celldex Therapeutics (CLDX) stock. Volume based technical analysis of Celldex Therapeutics (CLDX) stock is negative.
Celldex Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.